June 24, 2013
Beta Labs, LTD Announces a Recall of Dietary Supplements
The Missouri Department of Health and Senior Services received information regarding a recall of Beta Labs, LTD ("Beta"), dietary supplement. This retailer is recalling Oxyphen XR Lot #s 200910 and 200911, Phentalene Lot # 58800512, Phen FX Lot # 1205129, and Red Vipers Lot # 1205128. The recall was initiated on June 15, 2013, after a review of recent FDA communications related to 1, 3 dimethylamylamine ("DMAA"). The Products contain DMAA.
The UPC codes for each of the products are: Oxyphen XR, 70541 59974; Phentalene, 70541 59982; Phen FX, 29882 55980; Red Vipers, 29882 55981. The Products are all in capsule form. DMAA is commonly used as a stimulant, pre-workout, and weight loss ingredient in dietary supplement products. The Food and Drug Administration (FDA) has warned that DMAA is potentially dangerous to health. Ingestion of DMAA can elevate blood pressure and lead to cardiovascular problems. A number of adverse effects associated with DMAA containing dietary supplements have been reported to the FDA. The FDA has also warned that DMAA is not a dietary ingredient and thus, is not Dietary Supplement Health and Education Act (DSHEA) compliant.
This recall affects Oxyphen XR Lot #s 200910 and 200911, Phentalene Lot # 58800512, Phen FX Lot # 1205129, and Red Vipers Lot # 1205128. The products are in capsule form.
Beta distributes dietary supplements to retailers. The Products were sold via telephone in all fifty States. There have been no reports of adverse events associated with these Products to date. No other products distributed by Beta are subject to recall.
The full recall can be found at http://www.fda.gov/Safety/Recalls/ucm358236.htm?source=govdelivery